These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 830417)

  • 61. Glycosaminoglycan synthesis by a cell line (C1-S1) established from a preneoplastic mouse mammary outgrowth.
    Angello JC; Hosick HL; Anderson LW
    Cancer Res; 1982 Dec; 42(12):4975-8. PubMed ID: 7139602
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression by 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil of preneoplastic mammary hyperplastic alveolar nodule formation in SHN virgin mice.
    Sakamoto S; Mizuno M; Sawaki K; Kudo H; Kasahara N; Suzuki S; Mori T; Nagasawa H
    Anticancer Res; 1992; 12(4):1291-4. PubMed ID: 1503423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues.
    Wei WZ; Malone K; Mahoney K; Heppner G
    Cancer Res; 1986 Jun; 46(6):2680-5. PubMed ID: 3084071
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urethan-induced mammary tumorigenesis in a murine mammary tumor virus (MuMTV)-positive mouse strain: evidence for a keratinized nodule as an MuMTV-negative precursor lesion for squamous cell tumors.
    Imai S; Tsubura Y; Hilgers J
    J Natl Cancer Inst; 1984 Oct; 73(4):935-41. PubMed ID: 6090751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperplastic alveolar nodules of the rat mammary gland: tumor-producing capability in vivo and in vitro.
    Sinha D; Dao TL
    Cancer Lett; 1977 Jan; 2(3):153-60. PubMed ID: 402207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Morphology of the collateral mammae in induced mammary carcinoma in BALB/c/Cb/Se mice].
    Biancifiori C
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1977; 37(1):19-28. PubMed ID: 559894
    [No Abstract]   [Full Text] [Related]  

  • 68. Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.
    Medina D; Kittrell FS
    Carcinogenesis; 1993 Jan; 14(1):25-8. PubMed ID: 8425268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation.
    Medina D; Shepherd F; Gropp T
    J Natl Cancer Inst; 1978 May; 60(5):1121-6. PubMed ID: 205661
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.
    Medina D
    J Natl Cancer Inst; 1974 Jul; 53(1):213-21. PubMed ID: 4835107
    [No Abstract]   [Full Text] [Related]  

  • 71. Persistence of precursor cells of squamous metaplasia in preneoplastic mammary outgrowth lines from mice.
    Schaefer FV; Custer RP; Sorof S
    J Natl Cancer Inst; 1984 Jan; 72(1):185-9. PubMed ID: 6582297
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNA polymerase activity and DNA synthesis in preneoplastic nodule outgrowths of BALB-c and C3H mouse mammary gland.
    Banerjee MR; Mehta RG; Wagner JE
    J Natl Cancer Inst; 1973 Feb; 50(2):339-45. PubMed ID: 4349763
    [No Abstract]   [Full Text] [Related]  

  • 73. Proliferation of preneoplastic mammary nodule outgrowth in mammary fat pads of BALB-c mice in organ culture.
    Mehta RG; Washburn LL; Young PN; Banerjee MR; Bern HA
    J Natl Cancer Inst; 1974 Mar; 52(3):1013-7. PubMed ID: 4826552
    [No Abstract]   [Full Text] [Related]  

  • 74. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
    Medina D
    J Natl Cancer Inst; 1977 Apr; 58(4):1107-10. PubMed ID: 576622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Considerations on the preneoplastic lesions of the mammary gland.
    Gullino PM
    Am J Pathol; 1977 Nov; 89(2):413-30. PubMed ID: 200144
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serial transplantation of carcinogen-treated mammary nodule outgrowths. 3. Dissociation of carcinogen-induced cell variants by dose and chemical structure of carcinogen.
    Medina D
    J Natl Cancer Inst; 1973 Jun; 50(6):1555-9. PubMed ID: 4717566
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunoendocrine mechanisms in mammary tumor progression: direct prolactin modulation of peripheral and preneoplastic hyperplastic-alveolar-nodule- infiltrating lymphocytes.
    Tsai SC; Heppner GH
    Cancer Immunol Immunother; 1994 Nov; 39(5):291-8. PubMed ID: 7987860
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Melphalan, medphalan & merphalan.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():167-80. PubMed ID: 791831
    [No Abstract]   [Full Text] [Related]  

  • 79. Prolonged lactation in nodule bearing mice and its effect on mammary tumor genesis.
    Zeilmaker GH
    Eur J Cancer (1965); 1968 Aug; 4(4):447-8. PubMed ID: 5761459
    [No Abstract]   [Full Text] [Related]  

  • 80. Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.
    Simpson-Herren L; Noker PE; Wagoner SD
    Cancer Chemother Pharmacol; 1987; 20(4):297-304. PubMed ID: 3690803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.